Filing
Spy
Filing
Spy
Home
About
HALO
Halozyme Therapeutics Inc
0.25% Convertible Senior Notes due 2027
CUSIP: 40637H109
Healthcare
US
1 holder
Ownership
Activity
2023 Q1
9 of 25 quarters
Total Value
$352.0K
Total Shares
9.2K
Net Share Change
-5.3K
Activity
1 selling
Investor
Value
Shares
Weight
Change
Pzena Investment Management
$352.0K
9.2K
0.0%
TRIM
-5.3K
(-36.5%)
Pzena Investment Management
$352.0K
9.2K shares
TRIM
-5.3K
(-36.5%)
HALO — Halozyme Therapeutics Inc - FilingSpy